Selected research
Industry Research
Pentaerythritol Tetranitrate Industry Research Report 2026
Market perspective
The global Pentaerythritol Tetranitrate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pentaerythritol Tetranitrate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pentaerythritol Tetranitrate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pentaerythritol Tetranitrate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pentaerythritol Tetranitrate include Sichuan Shuangxin Pharmaceutical, Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd., Shandong Xinyi Pharmaceutical, Roxy Pharmaceuticals, Hebei Medical University, Beijing Yimin Pharmaceutical, Tathimfarmpreparaty and Dilcoran pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pentaerythritol Tetranitrate market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pentaerythritol Tetranitrate Market by Company
Sichuan Shuangxin Pharmaceutical
Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.
Shandong Xinyi Pharmaceutical
Roxy Pharmaceuticals
Hebei Medical University
Beijing Yimin Pharmaceutical
Tathimfarmpreparaty
Dilcoran pharmaceutical
Pentaerythritol Tetranitrate Segment by Type
Flaky
Powdery
Pentaerythritol Tetranitrate Segment by Application
Hospital
Clinic
Pentaerythritol Tetranitrate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pentaerythritol Tetranitrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pentaerythritol Tetranitrate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pentaerythritol Tetranitrate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pentaerythritol Tetranitrate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pentaerythritol Tetranitrate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pentaerythritol Tetranitrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Flaky
- Powdery
Applications
- Hospital
- Clinic
Companies covered
- Sichuan Shuangxin Pharmaceutical
- Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.
- Shandong Xinyi Pharmaceutical
- Roxy Pharmaceuticals
- Hebei Medical University
- Beijing Yimin Pharmaceutical
- Tathimfarmpreparaty
- Dilcoran pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pentaerythritol Tetranitrate Market Size (2021-2032)
- 2.2.2 Global Pentaerythritol Tetranitrate Sales (2021-2032)
- 2.2.3 Global Pentaerythritol Tetranitrate Market Average Price (2021-2032)
- 2.3 Pentaerythritol Tetranitrate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Flaky
- 2.3.3 Powdery
- 2.4 Pentaerythritol Tetranitrate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pentaerythritol Tetranitrate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pentaerythritol Tetranitrate Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Pentaerythritol Tetranitrate Revenue of Manufacturers (2021-2026)
- 3.4 Global Pentaerythritol Tetranitrate Average Price by Manufacturers (2021-2026)
- 3.5 Global Pentaerythritol Tetranitrate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pentaerythritol Tetranitrate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pentaerythritol Tetranitrate, Product Type & Application
- 3.8 Global Manufacturers of Pentaerythritol Tetranitrate, Established Date
- 3.9 Global Pentaerythritol Tetranitrate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sichuan Shuangxin Pharmaceutical
- 4.1.1 Sichuan Shuangxin Pharmaceutical Company Information
- 4.1.2 Sichuan Shuangxin Pharmaceutical Business Overview
- 4.1.3 Sichuan Shuangxin Pharmaceutical Pentaerythritol Tetranitrate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sichuan Shuangxin Pharmaceutical Pentaerythritol Tetranitrate Product Portfolio
- 4.1.5 Sichuan Shuangxin Pharmaceutical Recent Developments
- 4.2 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.
- 4.2.1 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Company Information
- 4.2.2 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Business Overview
- 4.2.3 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Pentaerythritol Tetranitrate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Pentaerythritol Tetranitrate Product Portfolio
- 4.2.5 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Recent Developments
- 4.3 Shandong Xinyi Pharmaceutical
- 4.3.1 Shandong Xinyi Pharmaceutical Company Information
- 4.3.2 Shandong Xinyi Pharmaceutical Business Overview
- 4.3.3 Shandong Xinyi Pharmaceutical Pentaerythritol Tetranitrate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shandong Xinyi Pharmaceutical Pentaerythritol Tetranitrate Product Portfolio
- 4.3.5 Shandong Xinyi Pharmaceutical Recent Developments
- 4.4 Roxy Pharmaceuticals
- 4.4.1 Roxy Pharmaceuticals Company Information
- 4.4.2 Roxy Pharmaceuticals Business Overview
- 4.4.3 Roxy Pharmaceuticals Pentaerythritol Tetranitrate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Roxy Pharmaceuticals Pentaerythritol Tetranitrate Product Portfolio
- 4.4.5 Roxy Pharmaceuticals Recent Developments
- 4.5 Hebei Medical University
- 4.5.1 Hebei Medical University Company Information
- 4.5.2 Hebei Medical University Business Overview
- 4.5.3 Hebei Medical University Pentaerythritol Tetranitrate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hebei Medical University Pentaerythritol Tetranitrate Product Portfolio
- 4.5.5 Hebei Medical University Recent Developments
- 4.6 Beijing Yimin Pharmaceutical
- 4.6.1 Beijing Yimin Pharmaceutical Company Information
- 4.6.2 Beijing Yimin Pharmaceutical Business Overview
- 4.6.3 Beijing Yimin Pharmaceutical Pentaerythritol Tetranitrate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Beijing Yimin Pharmaceutical Pentaerythritol Tetranitrate Product Portfolio
- 4.6.5 Beijing Yimin Pharmaceutical Recent Developments
- 4.7 Tathimfarmpreparaty
- 4.7.1 Tathimfarmpreparaty Company Information
- 4.7.2 Tathimfarmpreparaty Business Overview
- 4.7.3 Tathimfarmpreparaty Pentaerythritol Tetranitrate Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Tathimfarmpreparaty Pentaerythritol Tetranitrate Product Portfolio
- 4.7.5 Tathimfarmpreparaty Recent Developments
- 4.8 Dilcoran pharmaceutical
- 4.8.1 Dilcoran pharmaceutical Company Information
- 4.8.2 Dilcoran pharmaceutical Business Overview
- 4.8.3 Dilcoran pharmaceutical Pentaerythritol Tetranitrate Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Dilcoran pharmaceutical Pentaerythritol Tetranitrate Product Portfolio
- 4.8.5 Dilcoran pharmaceutical Recent Developments
5 Global Pentaerythritol Tetranitrate Market Scenario by Region
- 5.1 Global Pentaerythritol Tetranitrate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pentaerythritol Tetranitrate Sales by Region: 2021-2032
- 5.2.1 Global Pentaerythritol Tetranitrate Sales by Region: 2021-2026
- 5.2.2 Global Pentaerythritol Tetranitrate Sales by Region: 2027-2032
- 5.3 Global Pentaerythritol Tetranitrate Revenue by Region: 2021-2032
- 5.3.1 Global Pentaerythritol Tetranitrate Revenue by Region: 2021-2026
- 5.3.2 Global Pentaerythritol Tetranitrate Revenue by Region: 2027-2032
- 5.4 North America Pentaerythritol Tetranitrate Market Facts & Figures by Country
- 5.4.1 North America Pentaerythritol Tetranitrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pentaerythritol Tetranitrate Sales by Country (2021-2032)
- 5.4.3 North America Pentaerythritol Tetranitrate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pentaerythritol Tetranitrate Market Facts & Figures by Country
- 5.5.1 Europe Pentaerythritol Tetranitrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pentaerythritol Tetranitrate Sales by Country (2021-2032)
- 5.5.3 Europe Pentaerythritol Tetranitrate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pentaerythritol Tetranitrate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pentaerythritol Tetranitrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pentaerythritol Tetranitrate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pentaerythritol Tetranitrate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pentaerythritol Tetranitrate Market Facts & Figures by Country
- 5.7.1 South America Pentaerythritol Tetranitrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pentaerythritol Tetranitrate Sales by Country (2021-2032)
- 5.7.3 South America Pentaerythritol Tetranitrate Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pentaerythritol Tetranitrate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pentaerythritol Tetranitrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pentaerythritol Tetranitrate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pentaerythritol Tetranitrate Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pentaerythritol Tetranitrate Sales by Type (2021-2032)
- 6.1.1 Global Pentaerythritol Tetranitrate Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Pentaerythritol Tetranitrate Sales Market Share by Type (2021-2032)
- 6.2 Global Pentaerythritol Tetranitrate Revenue by Type (2021-2032)
- 6.2.1 Global Pentaerythritol Tetranitrate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pentaerythritol Tetranitrate Revenue Market Share by Type (2021-2032)
- 6.3 Global Pentaerythritol Tetranitrate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pentaerythritol Tetranitrate Sales by Application (2021-2032)
- 7.1.1 Global Pentaerythritol Tetranitrate Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Pentaerythritol Tetranitrate Sales Market Share by Application (2021-2032)
- 7.2 Global Pentaerythritol Tetranitrate Revenue by Application (2021-2032)
- 7.2.1 Global Pentaerythritol Tetranitrate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pentaerythritol Tetranitrate Revenue Market Share by Application (2021-2032)
- 7.3 Global Pentaerythritol Tetranitrate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pentaerythritol Tetranitrate Value Chain Analysis
- 8.1.1 Pentaerythritol Tetranitrate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pentaerythritol Tetranitrate Production Mode & Process
- 8.2 Pentaerythritol Tetranitrate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pentaerythritol Tetranitrate Distributors
- 8.2.3 Pentaerythritol Tetranitrate Customers
9 Global Pentaerythritol Tetranitrate Analyzing Market Dynamics
- 9.1 Pentaerythritol Tetranitrate Industry Trends
- 9.2 Pentaerythritol Tetranitrate Industry Drivers
- 9.3 Pentaerythritol Tetranitrate Industry Opportunities and Challenges
- 9.4 Pentaerythritol Tetranitrate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst